Seeking Alpha

Anika Therapeutics beats by $0.17, beats on revenue

  • Anika Therapeutics (ANIK): Q2 EPS of $0.40 beats by $0.17.
  • Revenue of $20.8M beats by $3.71M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: